Opportunities include identifying strategic regions for clinical trials, understanding enrollment trends, and analyzing trial success rates. The report aids investment strategies, saving time and cost ...

Kristie L. Kahl: In simple terms, can you explain what chronic lymphocytic is? Dr. Susan O’Brien: It’s a leukemia, which by definition means it's in the blood and in the bone marrow because inside ...

Dee and Jimmy Haslam, the managing partners of Haslam Sports Group and owners of the Cleveland Browns, are putting serious ...

Gastroenterologists and pathologists are recognizing nonbloody watery diarrhea owing to 'microscopic colitis' with increasing frequency; this disease is therefore an important clinical and ...

Monoclonal B-cell lymphocytosis (MBL) is when you have a high number of identical B cells, under 5,000 per microliter, for at least 3 months. It usually causes no symptoms or need for active treatment ...

Cancer that forms in blood and bone marrow is called chronic lymphocytic leukemia (CLL). In chronic lymphocytic leukemia, the word “chronic” denotes slow progress and the word "lymphocytic" means ...

Leukemia is a form of cancer that affects cells in the blood and bone marrow. It’s classified based on how fast the cancer grows (acute vs. chronic) and the kinds of cells affected (lymphocytic vs.

Chronic lymphocytic leukemia (CLL), also known as chronic lymphoid leukemia, is an oncological condition that is distinguished by the progressive accretion of non-functioning lymphocytes. It is the ...

Incorporating Immunotherapy Into the Treatment Strategies of B-Cell Adult Acute Lymphoblastic Leukemia: The Role of Blinatumomab and Inotuzumab Ozogamicin The advent of novel small molecule therapy ...

Researchers at Johns Hopkins have identified a POT1 gene mutation that causes unusually long telomeres, keeping immune cells ...

Relapsed and Refractory Classical Hodgkin Lymphoma: Keeping Pace With Novel Agents and New Options for Salvage Therapy The number of novel targeted agents approved for use in CLL has grown ...